Frontline Antibodies With BTK Inhibitors for CLL

16 Jan 2020 05:32 0
56
OncLiveTV Download
1 0

Panelists discuss the role of frontline antibodies with BTK inhibitors for the treatment of chronic lymphocytic leukemia.

Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive

Related of "Frontline Antibodies With BTK Inhibitors for CLL" Videos